Dr Jimmy Miller, MD | |
405 River Rd, Greenwood, MS 38930-4212 | |
(662) 451-7812 | |
Not Available |
Full Name | Dr Jimmy Miller |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 405 River Rd, Greenwood, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871553370 | NPI | - | NPPES |
04123847 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 08772 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jimmy Miller, MD Po Box 1410, Attn: Clinic Administration, Greenwood, MS 38935-1410 Ph: (662) 459-7189 | Dr Jimmy Miller, MD 405 River Rd, Greenwood, MS 38930-4212 Ph: (662) 451-7812 |
News Archive
How many millions of people suffer from sleep disturbance? One sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson's and dementia, say scientists presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.
Researchers from Rice University's Laboratory for Nanophotonics (LANP), the radiology department at Baylor College of Medicine (BCM) and the University of Texas MD Anderson Cancer Center are preparing to test a combined approach for diagnosing and treating pancreatic cancer with a specially engineered nanoparticle.
Saint Mary's and Sierra Neurosurgery Group have partnered to create the region's first Brain Tumor Center in an effort to speed up the time between diagnosis and treatment.
GlycoMimetics, Inc., a clinical stage biotechnology company developing a new class of glycobiology based therapies for a broad range of indications, today announced that the journal Blood has published pre-clinical data on the company's lead compound GMI-1070 in a model of sickle cell disease.
› Verified 7 days ago